CompletedPhase 2NCT01315938

Abatacept Treatment in Polymyositis and Dermatomyositis

Studying Dermatomyositis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Karolinska Institutet
Principal Investigator
Ingrid E Lundberg, MD, PhD
Karolinska Institutet
Intervention
Abatacept Active Treatment(drug)
Enrollment
20 enrolled
Eligibility
18-80 years · All sexes
Timeline
2011 – 2013

Study locations (2)

Collaborators

Institute of Rheumatology, Prague · King's College Hospital NHS Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01315938 on ClinicalTrials.gov

Other trials for Dermatomyositis

Additional recruiting or active studies for the same condition.

See all trials for Dermatomyositis →

← Back to all trials